Unknown OBSERVATIONAL NCT05675748

Real-world Study Evaluating the Efficacy and Safety of Azvudine in Nursing Home Patients

A Non-interventional Real-world Study Evaluating the Efficacy and Safety of Azvudine in Nursing Home Patients With Mild/Normal COVID-19

Sponsor: Huashan Hospital

Conditions COVID-19

Interventions Azvudine

Updated 4 times since 2023 Last updated: Jan 11, 2023 Started: Jan 15, 2023 Primary completion: Mar 15, 2023 Completion: Apr 15, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates COVID-19 and is currently ongoing. Huashan Hospital leads this study, which shows 4 recorded versions since 2023 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

4 versions recorded

Feb 2025 — Present [monthly]

Unknown

Status: Not Yet Recruiting → Unknown
Sep 2024 — Feb 2025 [monthly]

Not Yet Recruiting
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting
Feb 2023 — Jul 2024 [monthly]

Not Yet Recruiting

First recorded

Jan 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Huashan Hospital
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Shanghai Henlius Biotech

Data source: Shanghai Henlius Biotech

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.